Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Condition |
Hac1p
|
YJL034W
|
PubMed
Cox JS et al., Cell, 1996 Nov 1;87(3):391-404Cox JS et al., Cell, 1996 Nov 1;87(3):391-404 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
S288c |
tunicamycin treatment |
PubMed
Nikawa J et al., Nucleic Acids Res, 1996 Nov 1;24(21):4222-6Nikawa J et al., Nucleic Acids Res, 1996 Nov 1;24(21):4222-6 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
S288c |
tunicamycin treatment |
PubMed
Kawahara T et al., Mol Biol Cell, 1997 Oct;8(10):1845-62Kawahara T et al., Mol Biol Cell, 1997 Oct;8(10):1845-62 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
S288c |
SC medium; mid-log phase |
PubMed
Mori K et al., J Biol Chem, 1998 Apr 17;273(16):9912-20Mori K et al., J Biol Chem, 1998 Apr 17;273(16):9912-20 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Kimata Y et al., Genes Cells, 2006 Jan;11(1):59-69Kimata Y et al., Genes Cells, 2006 Jan;11(1):59-69 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
BY4742 |
Non-stressed vs tunicamycin (TM)-treated (2 microg/mL, 1 h) wt (WT) cells and cells harboring HAC1i mutation (HAC1u cells (Ire1-HAC1 pathway completely blocked) vs HAC1i cells (Ire1-HAC1 pathway constitutively activated) cultured without extrinsic ER stress) |
PubMed
Chua G et al., Proc Natl Acad Sci U S A, 2006 Aug 8;103(32):12045-50Chua G et al., Proc Natl Acad Sci U S A, 2006 Aug 8;103(32):12045-50 |
Indirect |
Microarray analysis - wt vs TF overexpression |
Positive |
N/A |
Cells grown in selective medium supplemented with 2% raffinose before induction with 2% galactose for 3 h |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Hou J et al., FEMS Yeast Res, 2014 May;14(3):481-94Hou J et al., FEMS Yeast Res, 2014 May;14(3):481-94 |
Indirect |
Microarray analysis - wt vs TF mutant |
Negative |
S288c |
DTT inhibition |
PubMed
Pincus D et al., Proc Natl Acad Sci U S A, 2014 Oct 14;111(41):14800-5Pincus D et al., Proc Natl Acad Sci U S A, 2014 Oct 14;111(41):14800-5 |
Indirect |
RNA-seq - wt vs TF overexpression |
Positive |
S288c |
DTT and Tunicamycin |
PubMed
Lee YM et al., Environ Microbiol, 2017 Feb;19(2):584-597Lee YM et al., Environ Microbiol, 2017 Feb;19(2):584-597 |
Indirect |
lacZ - wt vs TF mutant |
Positive |
BY4741 |
2 mM DTT for 2 hours |
PubMed
Van Dalfsen KM et al., Dev Cell, 2018 Jul 16;46(2):219-235.e8Van Dalfsen KM et al., Dev Cell, 2018 Jul 16;46(2):219-235.e8 |
Indirect |
RNA-seq - wt vs TF mutant |
Positive |
BrUn1362 |
Tunicamycin |
Indirect |
RNA-seq - wt vs TF mutant |
Positive |
BrUn1362 |
5mM DTT |
Indirect |
Ribo-seq: WT vs TF mutant |
Positive |
BrUn1362 |
Tunicamycin |
Indirect |
Ribo-seq: WT vs TF mutant |
Positive |
BrUn1362 |
5mM DTT |